Top 20 Key Players companies in Psilocybin by Highest Patent Value in the world in 2020 – Discovery

Free Trial

The Psilocybin top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Psilocybin Key Players in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Psilocybin (/ˌsaɪləˈsaɪbɪn/ sy-lə-SY-bin) is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms. The most potent are members of the genus Psilocybe, such as P. azurescens, P. semilanceata, and P. cyanescens, but psilocybin has also been isolated from about a dozen other genera. As a prodrug, psilocybin is quickly converted by the body to psilocin, which has mind-altering effects similar, in some aspects, to those of LSD, mescaline, and DMT. In general, the effects include euphoria, visual and mental hallucinations, changes in perception, a distorted sense of time, spiritual experiences, and can include possible adverse reactions such as nausea and panic attacks.

Ranking Year:

Region:

Ranking:

1	GlaxoSmithKline Biologicals SA	Belgium	Medicine,Rubella,Hepatitis, ...[+2]	Avg patent value: 3.05 M
2	Compass Pathways Plc	United Kingdom	Biology,Health care,Wellness Programs, ...[+2]	Avg patent value: 1.64 M
3	Teknologian Tutkimuskeskus VTT Oy	Southern Finland, Finland	Telecommunications,Applied research,Solar cell, ...[+2]	Avg patent value: 75,000
4	Psilo Scientific Ltd.	British Columbia, Canada	Drug discovery	Avg patent value: 60,980
5	STARTUP Lennham Pharmaceuticals, Inc.	Massachusetts, United States	Chemical compound,Experimental data,Health care	Avg patent value: 48,000
6	STARTUP CaaMTech LLC	Washington, United States	Patent portfolio	Avg patent value: 42,800
7	STARTUP Diamond Therapeutics	Ontario, Canada	Psychedelic drug,Biology,Pharmacy and Therapeutics, ...[+2]	Avg patent value: 27,000
8	Diamond Therapeutics, Inc.	Ontario, Canada	Psychedelic drug	Avg patent value: 27,000
9	STARTUP CB Therapeutics	California, United States	Cannabinoid,Pharmacy and Therapeutics,Cannabis, ...[+1]	Avg patent value: 17,000
10	STARTUP Pike Therapeutics, Inc.	Ontario, Canada	Botanical drug,Herb	Avg patent value: 15,000
11	Empyrean Neuroscience, Inc.	United States		Avg patent value: 14,000
12	STARTUP Synbionik GmbH	Hessen, Germany	Metabolic pathway,Organism	Avg patent value: 5,900
13	Insectergy LLC	MD, US		Avg patent value: 3,900
14	Mydecine Innovations Group, Inc.	British Columbia, Canada	Crop,Pharmacy,Land development, ...[+1]	Avg patent value: 0
15	Revive Therapeutics Ltd.	Ontario, Canada	Cannabis,Drug,Medicine, ...[+2]	Avg patent value: 0
16	Zosano Pharma Corp.	California, United States	Severe osteoporosis,Medicine,Health care, ...[+2]	Avg patent value: 0
17	Sandoz AG	Switzerland	Botanical drug,Herb	Avg patent value: 0
18	Mindset Pharma, Inc.	Ontario, Canada	Neurological disorder	Avg patent value: 0
19	Silo Pharma, Inc.	New Jersey, United States	E-commerce,Social consciousness,Music, ...[+2]	Avg patent value: 0
20	NeonMind Biosciences, Inc.	British Columbia, Canada	Mushroom,Smartwatch,Pharmacy, ...[+1]	Avg patent value: 0